ClinicalTrials.Veeva

Menu

Awe Inducing Elements in Virtual Reality Applications: A Prospective Study of Hospitalized Children

Stanford University logo

Stanford University

Status

Completed

Conditions

Awe

Treatments

Behavioral: Virtual Reality
Other: Control

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is an experimental study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers (e.g., parents, guardians)

Full description

Hospitalized pediatric patients, especially those undergoing anesthesia and surgery, experience anxiety and fear, resulting in lack of cooperation, withdrawal, and aggression. These reactions delay medical care and negatively impact patient experience.

This is an experimental, prospective study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers. The primary center for this study will be Lucile Packard Children's Hospital Stanford (LPCHS) (located within Stanford University, Palo Alto, CA).

After software development, we will evaluate the awe and engagement of pediatric patients after experiencing the novel virtual reality application.

Enrollment

202 patients

Sex

All

Ages

6 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with age range from 6 to 25
  • Adult or LAR with age range from 18 to 99
  • Able to consent or have parental consent
  • in pre-operative holding and inpatient acute care areas of LCPH
  • English speaking participants

Exclusion criteria

  • People who do not consent
  • Significant Cognitive Impairment
  • History of Severe Motion Sickness
  • Visual Problems
  • currently have nausea
  • history of seizures
  • non-english participants

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

202 participants in 2 patient groups

Virtual Reality
Experimental group
Description:
Virtual reality intervention will be given 6 times in total and each session will last not more than 60 seconds.
Treatment:
Behavioral: Virtual Reality
Control
Other group
Description:
Participants will serve as their own controls. Participants will not be given any VR intervention at first but they are requested to fill out the survey to collect the baseline data.
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Caruso, MD; Man Yee Suen, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems